Top Markets
Coin of the day
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Pozycja w akcjach #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Cena akcji
$16.36
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$753.27M
Zmiana (1 dzień)
0.51%
Zmiana (1 rok)
108.95%
Kraj
IN
Handel Senores Pharmaceuticals Ltd. (SENORES)

Kategoria

Historia stopy dywidendy dla Senores Pharmaceuticals Ltd. (SENORES)
Stopa dywidendy (TTM) dla Senores Pharmaceuticals Ltd. (symbol akcji: SENORES) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Senores Pharmaceuticals Ltd. (SENORES) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.57%
US
2.01%
US
2.74%
US
2.69%
CH
2.47%
US